top of page

Innovative Enhancement of Medicines

Innovative Enhancement of Medicines

LP Pharma focuses on unique formulation platforms for developing enhanced drug delivery options, including mucosal and oral controlled release, across a wide range of therapeutic areas.

LP Pharma has substantial product development experience in CNS, Oncology Supportive Care, and other specialty therapeutic areas.

 

We have successfully received multiple US FDA ANDA approvals. Our facilities include GMP-certified, commercial-scale manufacturing for solid dosage forms and injectables.

Pilot-scale manufacturing and technical services are available.

 

LP Pharma is actively seeking global commercial partners, especially or the US and European markets, and we are interested in in-licensing and partnerships for the China market.

Contact Us to discuss further

NEW Product - Oct 2024.png
bottom of page